Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Effects of Transcranial Direct Current Stimulation and Transcranial Alternating Current Stimulation on Neuropathic Pain, Manual Dexterity and Strength in Diabetic Peripheral Neuropathic Patients.

NCT07905729 is registered in ClinicalTrials.gov with University of Management and Technology Lahore as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07905729 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Effects of Transcranial Direct Current Stimulation and Transcranial Alternating Current Stimulation on Neuropathic Pain, Manual Dexterity and Strength in Diabetic Peripheral Neuropathic Patients.
Lead sponsor
University of Management and Technology Lahore
Phase
Not applicable
Overall status
Active, not recruiting
Start date
October 22, 2026
Completion date
December 31, 2026
Enrollment
46 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic peripheral neuropathy (dpn)

Arms

As registered; 2 arms.

  • Transcranial Direct Current Stimulation (tDCS) with Conventional Physical Therapy ExperimentalTranscranial Direct Current Stimulation (tDCS)

    Transcranial Direct Current Stimulation (tDCS) will be applied over the primary motor cortex (M1) hand area corresponding to the C3 position according to the International 10-20 EEG system. The anodal electrode will be positioned over C3, while the cathodal electrode will be placed over the right supraorbital region. Saline-soaked sponge electrodes measuring 5 × 5 cm will be used for stimulation. A direct current of 2 mA will be delivered for 20 minutes per session. The intervention will be administered once daily, five days per week, for a total of 20 sessions over a period of 4 weeks

  • Transcranial Alternating Current Stimulation (tACS) with Conventional Physical Therapy Active comparatorTranscranial Alternating Current Stimulation (tACS)

    Transcranial Alternating Current Stimulation (tACS) will be applied targeting the frontal cortex and the primary motor cortex (M1). Stimulation will be delivered at an intensity of 2 mA with a frequency of 5 -10 Hz bilaterally. Each treatment session will last 20 minutes. The intervention will be administered daily for five days per week according to the treatment schedule. Standardized electrode placement and stimulation parameters will be maintained throughout the intervention period to ensure consistency across sessions

Primary endpoints

Registered primary outcome measures; 3 primary.

  • Pain by McGill Pain Questionnaire-2 at baseline and after 4th week

    The MPQ-2 is a self-report questionnaire designed to evaluate different dimensions of pain, including continuous, intermittent, neuropathic, and affective pain descriptors. The questionnaire consists of 22 pain descriptors, each rated on an 11-point numerical scale ranging from 0 (none) to 10 (worst possible).

  • Isometric Muscle Strength by digital force gauge SF-500 at baseline and after 4th week

    It will measure muscle groups such as shoulder flexors, extensors, abductors, adductors, elbow flexors and extensors, wrist flexors and extensors in Kg. Before the test, a standard instruction of "push as hard as you can" will give, and during the test, the patients will be encourage to apply maximal effort. Maximal strength will exerted for 3 to 5 seconds, at which point the examiner instructed the person to relax. Maximal isometric muscle strength will recorded for all measured upper-extremity muscle groups

  • Manual Dexterity by Wooden 9 hole peg test at baseline and after 4th week

    The NHPT consists of a rectangular base and 9 pegs (7 mm in diameter, 32 mm in length). The base is divided into two parts; the container is located where the pegs will be housed in one, while a pegboard composed of 9 holes (10 mm in diameter, 15 mm deep) in which each of the pegs will be inserted is in the other. The pegboard will centered in front of the subject with the container side on the same side as the hand being tested. The dominant hand will tested first. Subjects completed one practice trial followed by the actual timed test for each hand

Lead sponsor's other trials

University of Management and Technology Lahore, most recent start first.

Similar trials

Same condition (Neuralgia) and phase, most recent start first.